Cellular, Molecular and Clinical Determinants of Bone Strength in in Vivo and Human Models of GH Excess.

Recruiting Observational Study
Acromegaly
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
100 (estimated)
Sponsor
IRCCS San Raffaele · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

Prospective observational clinical, molecular, translational study aimed at identifying the main determinants and predictive factors of fragility fracture risck in acromegaly patients

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * confirmed diagnosis of acromegaly * availability to carry out outpatient checks * ability to provide informed consent Exclusion Criteria: * Pregnancy * use of glucocorticoids (except those in use for replacement therapy) * alcohol abuse * exacerbation of chronic disease * se…
Contacts

Stefano Frara, MD

+390226435136

frara.stefano@hsr.it

CONTACT

Gabriela Felipe, Nurse

+390226435136

felipe.gabriela@hsr.it

CONTACT